GlassScriptPhysician profile
David Todd Ritchie
NPI 1598394488
$2,481.40
in general payments reported to CMS, 2019-2025
9 companies · $2,412 in 2025
The $2,412 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $69.14 · 2025: $2,412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,362 · Travel and Lodging: $1,119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,362.11 |
| Travel and Lodging | $1,119.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,318.74 | 2025 | Advantagerib, Ribfix Titan, Sternalock 360 System |
| Davol INC. | $388.53 | 2025 | Phasix Mesh |
| Atricure, INC. | $189.08 | 2023-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Kerecis Limited | $151.94 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $124.80 | 2025 | Collagenase Santyl, Oasis, Versajet |
| Bard Peripheral Vascular, INC. | $108.65 | 2025 | Rotarexs 6 F X 135 Cm |
| Takeda Pharmaceuticals U.S.A., INC. | $108.43 | 2025 | Gattex |
| Avita Medical Americas, LLC | $54.36 | 2025 | Cohealyx, Recell, Permeaderm |
| Kci USA, INC. | $36.87 | 2023 | V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice, Abthera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ritchie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.